Mackay Shields LLC’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-74,875
| Closed | -$1.21M | – | 984 |
|
|
2021
Q1 | $1.21M | Sell |
74,875
-44,951
| -38% | -$729K | 0.01% | 946 |
|
|
2020
Q4 | $2.54M | Sell |
119,826
-9,800
| -8% | -$207K | 0.02% | 752 |
|
|
2020
Q3 | $1.92M | Buy |
129,626
+21,200
| +20% | +$314K | 0.01% | 808 |
|
|
2020
Q2 | $1.6M | Buy |
108,426
+35,500
| +49% | +$522K | 0.01% | 856 |
|
|
2020
Q1 | $856K | Buy |
72,926
+10,800
| +17% | +$127K | 0.01% | 996 |
|
|
2019
Q4 | $1.46M | Sell |
62,126
-14,600
| -19% | -$343K | 0.01% | 975 |
|
|
2019
Q3 | $1.42M | Buy |
76,726
+1,800
| +2% | +$33.3K | 0.01% | 1030 |
|
|
2019
Q2 | $1.39M | Buy |
74,926
+50,451
| +206% | +$938K | 0.01% | 1038 |
|
|
2019
Q1 | $598K | Buy |
24,475
+500
| +2% | +$12.2K | ﹤0.01% | 1144 |
|
|
2018
Q4 | $622K | Buy |
23,975
+1,575
| +7% | +$40.9K | 0.01% | 1086 |
|
|
2018
Q3 | $709K | Buy |
+22,400
| New | +$709K | 0.01% | 945 |
|